Dupixent 300 MG/2 ML pen 2ML
Ended Awarded Last action
- Contract number
- SPE2DR26F47BL
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $38,838
Award facts
- Contract value 100% obligated
- $38,837.80 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $38,837.80 to AmerisourceBergen Drug Corp for the supply of Dupixent (dupilumab) 300 mg/2 mL pen injectors on January 6, 2026, with completion anticipated by January 7, 2026. This competitive, firm fixed-price award carries no set-aside designation and represents a routine pharmaceutical procurement fulfilled from the contractor's place of performance in Conshohocken, Pennsylvania. Dupixent is a biologic medication used to treat moderate-to-severe eczema, asthma, and chronic rhinosinusitis, making this delivery order part of the federal government's ongoing medical supply requirements for military and veteran healthcare systems.
This delivery order operates under AmerisourceBergen Drug Corp's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical, a $999,999,999.00 comprehensive pharmaceutical supply vehicle extending through December 2031. The IDC serves as the primary contracting mechanism through which Cencora supplies an extensive portfolio of specialty medications, brand-name and generic drugs, vaccines, and medical supplies to support military treatment facilities and federal healthcare programs globally. AmerisourceBergen's consistent performance on such competitively awarded delivery orders demonstrates its established capability to meet federal pharmaceutical procurement requirements efficiently and at firm fixed prices across diverse therapeutic domains.
Quick answers
Who was awarded contract SPE2DR26F47BL?
SPE2DR26F47BL was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 6, 2026.
How much is contract SPE2DR26F47BL worth?
The government has obligated $38,838 on SPE2DR26F47BL.
Is contract SPE2DR26F47BL an order under another contract?
Yes. SPE2DR26F47BL is a delivery order under SPE2DR25D2101, an indefinite delivery contract.
Was contract SPE2DR26F47BL competed?
The extent of competition for SPE2DR26F47BL was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award